TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/3/23 16:20 | 12/29/22 | OGEN | Oragenics Inc | FL | Health | Drug | Pharmaceutical Preparations | Koski Robert C | FL | D | S.m | -8 | 0.1057 | 0 | -79 | -6 | 1,278 | M | |||||||||||||||
12/16/22 16:05 | 12/14/22 | OGEN | Oragenics Inc | FL | Health | Drug | Pharmaceutical Preparations | Koski Robert C | FL | D | S.m | -29 | 0.1757 | 0 | -165 | -11 | 1,357 | I | |||||||||||||||
12/15/22 16:15 | 12/14/22 | OGEN | Oragenics Inc | FL | Health | Drug | Pharmaceutical Preparations | Koski Robert C | FL | D | S | -1 | 0.1750 | 0 | -5 | 0 | 1,523 | I | |||||||||||||||
12/12/22 16:22 | 12/9/22 | OGEN | Oragenics Inc | FL | Health | Drug | Pharmaceutical Preparations | Koski Robert C | FL | D | S | -10 | 0.1970 | 0 | -49 | -3 | 1,581 | I | |||||||||||||||
12/9/22 16:14 | 12/8/22 | OGEN | Oragenics Inc | FL | Health | Drug | Pharmaceutical Preparations | Koski Robert C | FL | D | S | -3 | 0.2000 | 0 | -13 | -1 | 1,629 | I | |||||||||||||||
12/1/22 16:08 | 11/29/22 | OGEN | Oragenics Inc | FL | Health | Drug | Pharmaceutical Preparations | Koski Robert C | FL | D | S.m | -77 | 0.1917 | 0 | -400 | -20 | 1,642 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |